Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...
Experts warn that excessive saliva, or drooling, could be a potential indicator of motor neurone disease (MND), a condition ...
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...
Tiziana Life Sciences (TLSA) announced the submission of its Investigational New Drug, IND, application to the U.S. Food and Drug ...
Tiziana Life Sciences (NASDAQ:TLSA) rises after the company said it is planning the submission of its Investigational New ...
The experts say if you notice that you produce a "lot of saliva (drool)", then this could indicate motor neurone disease (MND ...
Donald Trump’s health has sparked debate after a video showed him limping during a golf outing. While some speculate about ...
The poorly photoshopped version of a picture of Donald Trump's foot has caused an uproar on X, with users now poking fun at ...
HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...
Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for argenx in a research report issued to clients ...
Stockhead on MSN22h
Dr Boreham’s Crucible: This MSA-tackling biotech strives to be ‘different’Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback